NasdaqCM - Nasdaq Real Time Price USD

The Oncology Institute, Inc. (TOIIW)

0.0600
+0.0132
+(28.03%)
As of 11:40:12 AM EDT. Market Open.

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Richard Alan Barasch Chairman of the Board -- -- 1954
Dr. Daniel Virnich FACHE, M.B.A., M.D. CEO & Executive Director 704.25k -- 1979
Mr. Jeremy N. Castle M.B.A. Chief Operations Officer 475.95k -- 1984
Dr. Yale D. Podnos F.A.C.S., M.D., M.P.H. Chief Medical Officer 573.76k -- 1972
Mr. Robert Carter Chief Financial Officer -- -- 1986
Mr. Austin Lee VP of Accounting & Controller -- -- --
Mr. Mark Hueppelsheuser Esq. General Counsel -- -- --
Mr. Jordan McInerney Chief Development Officer -- -- --
Mr. Stephen Cella Senior Vice President of Finance -- -- --

The Oncology Institute, Inc.

18000 Studebaker Road
Suite 800
Cerritos, CA 90703
United States
562 735 3226 https://theoncologyinstitute.com
Sector: 
Healthcare
Full Time Employees: 
825

Description

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance services. The company also provides and manages clinical trials, palliative care programs, stem cell transplants services, other care delivery models associated with non-community-based academic, and tertiary care settings; and conducts clinical trials for a range of pharmaceutical, and medical device companies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

Corporate Governance

The Oncology Institute, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

Related Tickers